{"transactions":[{"id":2524418,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":133831,"kind":"person","name":"Jeong Tae Heum","position":1,"cik":"0001317190","reported_name":"Jeong Tae Heum","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-11-04T18:58:55.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 4, 2021 as an option for 62,500 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest  with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested"}],"balance_after":62500,"derivative":{"exercise_price":4.74,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001562180-21-006856","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317190/000156218021006856/primarydocument.xml","form_type":"4"}},{"id":2734399,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":133831,"kind":"person","name":"Jeong Tae Heum","position":1,"cik":"0001317190","reported_name":"Jeong Tae Heum","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-04-30T17:21:26.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest in 24 equal installments on the last day of each calendar month, beginning May 31,2021, until fully vested"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest in 24 equal installments on the last day of each calendar month, beginning May 31,2021, until fully vested"}],"balance_after":20000,"derivative":{"exercise_price":9,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-21-003064","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317190/000156218021003064/primarydocument.xml","form_type":"4"}},{"id":2881363,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":133831,"kind":"person","name":"Jeong Tae Heum","position":1,"cik":"0001317190","reported_name":"Jeong Tae Heum","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-02-03T20:51:42.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":130000,"price":6.55,"value":851500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option\nvests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested."},{"field":"shares","element":"transactionShares","label":"F1","text":"This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option\nvests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option\nvests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option\nvests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option\nvests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested."}],"balance_after":130000,"derivative":{"exercise_price":6.55,"exercise_date":"2021-03-01","expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001562180-21-000886","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317190/000156218021000886/primarydocument.xml","form_type":"4"}},{"id":3310696,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":133831,"kind":"person","name":"Jeong Tae Heum","position":1,"cik":"0001317190","reported_name":"Jeong Tae Heum","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2020-01-15T19:12:48.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments beginning on 2/13/2020, such that the option will be fully vested on the third anniversary of the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":8.39,"expiration_date":"2030-01-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001683168-20-000159","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317190/000168316820000159/ownership.xml","form_type":"4"}},{"id":4482904,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":133831,"kind":"person","name":"Jeong Tae Heum","position":1,"cik":"0001317190","reported_name":"Jeong Tae Heum","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-24T17:52:48.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018."}],"balance_after":63000,"derivative":{"underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001140361-17-002737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317190/000114036117002737/form4.xml","form_type":"4"}},{"id":4482903,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":133831,"kind":"person","name":"Jeong Tae Heum","position":1,"cik":"0001317190","reported_name":"Jeong Tae Heum","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-24T17:52:48.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on January 20, 2018, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested."}],"balance_after":300000,"derivative":{"exercise_price":0.184,"expiration_date":"2027-01-20","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-17-002737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317190/000114036117002737/form4.xml","form_type":"4"}}]}